These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23010731)

  • 41. Reducing margins of wide local excision in head and neck melanoma for function and cosmesis: 5-year local recurrence-free survival.
    Rawlani R; Rawlani V; Qureshi HA; Kim JY; Wayne JD
    J Surg Oncol; 2015 Jun; 111(7):795-9. PubMed ID: 25712156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
    Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
    Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.
    Karakousis CP; Balch CM; Urist MM; Ross MM; Smith TJ; Bartolucci AA
    Ann Surg Oncol; 1996 Sep; 3(5):446-52. PubMed ID: 8876886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
    Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
    Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The safety of and indications for immediate reconstruction of head and neck melanoma defects: our early experience.
    Parrett BM; Kashani-Sabet M; Leong SP; Buncke N; Singer MI
    Ann Plast Surg; 2014 May; 72 Suppl 1():S35-7. PubMed ID: 24691340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of staged excision with permanent section margin control for melanoma in situ.
    Reynolds HH; Stancut E; Pavlidakey PG; Huang CC; Phillips CB
    J Am Acad Dermatol; 2020 Oct; 83(4):1163-1164. PubMed ID: 32473972
    [No Abstract]   [Full Text] [Related]  

  • 49. Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.
    Ringborg U; Andersson R; Eldh J; Glaumann B; Hafström L; Jacobsson S; Jönsson PE; Johansson H; Krysander L; Lagerlöf B
    Cancer; 1996 May; 77(9):1809-14. PubMed ID: 8646678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.
    Balch CM; Urist MM; Karakousis CP; Smith TJ; Temple WJ; Drzewiecki K; Jewell WR; Bartolucci AA; Mihm MC; Barnhill R
    Ann Surg; 1993 Sep; 218(3):262-7; discussion 267-9. PubMed ID: 8373269
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical margins for excision of primary cutaneous melanoma.
    Zitelli JA; Brown CD; Hanusa BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study.
    Brantsch KD; Meisner C; Schönfisch B; Trilling B; Wehner-Caroli J; Röcken M; Breuninger H
    Lancet Oncol; 2008 Aug; 9(8):713-20. PubMed ID: 18617440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
    Mohebati A; Ganly I; Busam KJ; Coit D; Kraus DH; Shah JP; Patel SG
    Ann Surg Oncol; 2012 Dec; 19(13):4307-13. PubMed ID: 22766985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of regional recurrence after negative sentinel lymph node biopsy for head and neck melanoma.
    McDonald K; Page AJ; Jordan SW; Chu C; Hestley A; Delman KA; Murray DR; Carlson GW
    Head Neck; 2013 May; 35(5):667-71. PubMed ID: 22847953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors influencing time between biopsy and definitive surgery for malignant melanoma: do they impact clinical outcome?
    Carpenter S; Pockaj B; Dueck A; Gray R; Kurtz D; Sekulic A; Casey W
    Am J Surg; 2008 Dec; 196(6):834-42; discussion 842-3. PubMed ID: 19095097
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Worse outcome for patients with recurrent melanoma after negative sentinel lymph biopsy as compared to sentinel-positive patients.
    Gambichler T; Scholl L; Bechara FG; Stockfleth E; Stücker M
    Eur J Surg Oncol; 2016 Sep; 42(9):1420-6. PubMed ID: 27160354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional control of head and neck melanoma with selective neck dissection.
    Geltzeiler M; Monroe M; Givi B; Vetto J; Andersen P; Gross N
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1014-8. PubMed ID: 25275362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Excision margins in high-risk malignant melanoma.
    Thomas JM; Newton-Bishop J; A'Hern R; Coombes G; Timmons M; Evans J; Cook M; Theaker J; Fallowfield M; O'Neill T; Ruka W; Bliss JM; ; ;
    N Engl J Med; 2004 Feb; 350(8):757-66. PubMed ID: 14973217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early recurrence in sentinel lymph node positive stage III melanoma patients.
    Baker JJ; Ollila DW; Deal AM; Frank J; Amos KD; Meyers MO
    Am Surg; 2012 Jul; 78(7):808-13. PubMed ID: 22748543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.